Sep 12, 2023
1:16
For every 16 shares held, investors received 1.
The split itself did not change the total investment value.
Dianthus Therapeutics, Inc. (XETR:87E) operates in the Biotechnology industry.
Dianthus Therapeutics, Inc. company overviewDianthus Therapeutics, Inc.'s most recent stock split was on September 12, 2023. It was a 1-for-16 reverse split, so shareholders received 1 share for every 16 they held.
Dianthus Therapeutics, Inc. has split its stock once. This history records one reverse split, on September 12, 2023.
A reverse stock split combines several shares into one and raises the price per share by the same factor, so the total value of a holding does not change. In Dianthus Therapeutics, Inc.'s 1-for-16 reverse split on September 12, 2023, every 16 shares became one share. Companies often use reverse splits to lift a low share price, for example to keep meeting an exchange's minimum price requirement.
Dianthus Therapeutics, Inc. has not announced a new split in our records. Its most recent split was on September 12, 2023, 3 years ago. Companies announce splits in advance, and any new XETR:87E split will appear on this page.